These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 34663321

  • 1. A synergistic effect of variability in estimated glomerular filtration rate with chronic kidney disease on all-cause mortality prediction in patients with type 2 diabetes: a retrospective cohort study.
    Chang YS, Li YH, Lee IT.
    Cardiovasc Diabetol; 2021 Oct 18; 20(1):209. PubMed ID: 34663321
    [Abstract] [Full Text] [Related]

  • 2. Annual deterioration of renal function in hypertensive patients with and without diabetes.
    Polonia J, Azevedo A, Monte M, Silva JA, Bertoquini S.
    Vasc Health Risk Manag; 2017 Oct 18; 13():231-237. PubMed ID: 28721063
    [Abstract] [Full Text] [Related]

  • 3. Variability in estimated glomerular filtration rate values is a risk factor in chronic kidney disease progression among patients with diabetes.
    Tseng CL, Lafrance JP, Lu SE, Soroka O, Miller DR, Maney M, Pogach LM.
    BMC Nephrol; 2015 Mar 25; 16():34. PubMed ID: 25885708
    [Abstract] [Full Text] [Related]

  • 4. Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk.
    Rosenstock J, Perkovic V, Alexander JH, Cooper ME, Marx N, Pencina MJ, Toto RD, Wanner C, Zinman B, Baanstra D, Pfarr E, Mattheus M, Broedl UC, Woerle HJ, George JT, von Eynatten M, McGuire DK, CARMELINA® investigators.
    Cardiovasc Diabetol; 2018 Mar 14; 17(1):39. PubMed ID: 29540217
    [Abstract] [Full Text] [Related]

  • 5. Glycated Hemoglobin Level and Mortality in a Nondiabetic Population with CKD.
    Trivin C, Metzger M, Haymann JP, Boffa JJ, Flamant M, Vrtovsnik F, Houillier P, Stengel B, Thervet E, NephroTest Study Group.
    Clin J Am Soc Nephrol; 2015 Jun 05; 10(6):957-64. PubMed ID: 25979978
    [Abstract] [Full Text] [Related]

  • 6. Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease.
    Wanner C, Lachin JM, Inzucchi SE, Fitchett D, Mattheus M, George J, Woerle HJ, Broedl UC, von Eynatten M, Zinman B, EMPA-REG OUTCOME Investigators.
    Circulation; 2018 Jan 09; 137(2):119-129. PubMed ID: 28904068
    [Abstract] [Full Text] [Related]

  • 7. Parallel assessment of albuminuria and plasma sTNFR1 in people with type 2 diabetes and advanced chronic kidney disease provides accurate prognostication of the risks of renal decline and death.
    Martin WP, Tuohy C, Doody A, Jackson S, Canavan RJ, Slattery D, Twomey PJ, McKenna MJ, le Roux CW, Docherty NG.
    Sci Rep; 2020 Sep 09; 10(1):14852. PubMed ID: 32908199
    [Abstract] [Full Text] [Related]

  • 8. Change in the estimated glomerular filtration rate over time and risk of all-cause mortality.
    Turin TC, Coresh J, Tonelli M, Stevens PE, de Jong PE, Farmer CK, Matsushita K, Hemmelgarn BR.
    Kidney Int; 2013 Apr 09; 83(4):684-91. PubMed ID: 23344477
    [Abstract] [Full Text] [Related]

  • 9. Use of estimated glomerular filtration rate to predict incident chronic kidney disease in patients at risk of cardiovascular disease: a retrospective study.
    Al-Shamsi S, Oulhaj A, Regmi D, Govender RD.
    BMC Nephrol; 2019 Aug 20; 20(1):325. PubMed ID: 31429712
    [Abstract] [Full Text] [Related]

  • 10. The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study.
    Oshima M, Jun M, Ohkuma T, Toyama T, Wada T, Cooper ME, Hadjadj S, Hamet P, Harrap S, Mancia G, Marre M, Williams B, Chalmers J, Woodward M, Perkovic V, ADVANCE Collaborative Group.
    Diabetologia; 2019 Nov 20; 62(11):1988-1997. PubMed ID: 31302707
    [Abstract] [Full Text] [Related]

  • 11. Chronic kidney disease, cardiovascular disease and mortality: A prospective cohort study in a multi-ethnic Asian population.
    Lim CC, Teo BW, Ong PG, Cheung CY, Lim SC, Chow KY, Meng CC, Lee J, Tai ES, Wong TY, Sabanayagam C.
    Eur J Prev Cardiol; 2015 Aug 20; 22(8):1018-26. PubMed ID: 24857889
    [Abstract] [Full Text] [Related]

  • 12. National survey: Evaluation of cardiovascular risk factors in Thai patients with type 2 diabetes and chronic kidney disease after the development of cardiovascular disease.
    Changsirikulchai S, Sangthawan P, Janma J, Sripaiboonkij N, Rattanamongkolgul S, Thinkhamrop B.
    Nephrology (Carlton); 2018 Jan 20; 23(1):53-59. PubMed ID: 27608176
    [Abstract] [Full Text] [Related]

  • 13. Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study.
    Penno G, Solini A, Bonora E, Orsi E, Fondelli C, Zerbini G, Trevisan R, Vedovato M, Cavalot F, Laviola L, Nicolucci A, Pugliese G, Renal Insufficiency and Cardiovascular Events (RIACE) Study Group.
    Acta Diabetol; 2018 Jun 20; 55(6):603-612. PubMed ID: 29574497
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience.
    Chen PM, Wada T, Chiang CK.
    Clin Exp Nephrol; 2017 Apr 20; 21(2):307-315. PubMed ID: 27339442
    [Abstract] [Full Text] [Related]

  • 15. Comparison of cystatin C- and creatinine-based estimated glomerular filtration rates for predicting all-cause mortality in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry.
    Ide H, Iwase M, Fujii H, Ohkuma T, Kaizu S, Jodai T, Kikuchi Y, Idewaki Y, Sumi A, Nakamura U, Kitazono T.
    Clin Exp Nephrol; 2017 Jun 20; 21(3):383-390. PubMed ID: 27339449
    [Abstract] [Full Text] [Related]

  • 16. Association between renal function and cardiovascular and all-cause mortality in the community-based elderly population: results from the Specific Health Check and Guidance Program in Japan.
    Kon S, Konta T, Ichikawa K, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, Narita I, Kasahara M, Shibagaki Y, Iseki K, Moriyama T, Kondo M, Watanabe T.
    Clin Exp Nephrol; 2018 Apr 20; 22(2):346-352. PubMed ID: 28744566
    [Abstract] [Full Text] [Related]

  • 17. Effect of chronic kidney disease on A1C in individuals being screened for diabetes.
    Shipman KE, Jawad M, Sullivan KM, Ford C, Gama R.
    Prim Care Diabetes; 2015 Apr 20; 9(2):142-6. PubMed ID: 24893965
    [Abstract] [Full Text] [Related]

  • 18. Perioperative and long-term impact of chronic kidney disease on carotid artery interventions.
    Klarin D, Lancaster RT, Ergul E, Bertges D, Goodney P, Schermerhorn ML, Cambria RP, Patel VI, Vascular Study Group of New England.
    J Vasc Surg; 2016 Nov 20; 64(5):1295-1302. PubMed ID: 27776697
    [Abstract] [Full Text] [Related]

  • 19. Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25).
    Yokoyama H, Araki S, Haneda M, Matsushima M, Kawai K, Hirao K, Oishi M, Sugimoto K, Sone H, Maegawa H, Kashiwagi A, Japan Diabetes Clinical Data Management Study Group.
    Diabetologia; 2012 Jul 20; 55(7):1911-8. PubMed ID: 22476921
    [Abstract] [Full Text] [Related]

  • 20. Fibroblast growth factor 23 and incident CKD in type 2 diabetes.
    Isakova T, Craven TE, Lee J, Scialla JJ, Xie H, Wahl P, Marcovina SM, Byington RP, Wolf M.
    Clin J Am Soc Nephrol; 2015 Jan 07; 10(1):29-38. PubMed ID: 25343949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.